Mergers & AcquisitionsBy The Online Investor Staff, updated Sat., Sep. 19, 8:43 AM
|This Slide: #13 of 100|
Slide #13. Enzolytics, Inc. — BioClonetics Immunotherapeutics, Inc.
Enzolytics, Inc. (ENZC)
BioClonetics Immunotherapeutics, Inc.
Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced the execution of a non-binding letter of intent (the "LOI") to merge with BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas.